VEGFR2 Inhibitors [MoA] class drugs

1 result
  • cyramza - ramucirumab solution

    (Ramucirumab)
    Eli Lilly And Company
    Cyramza (ramucirumab) treats advanced gastric, gastro-esophageal junction, non-small cell lung, colorectal, and hepatocellular cancers in adults, used alone or with chemotherapy after prior treatment failure or as first-line therapy for EGFR-mutant NSCLC.